IMS Legal Strategies is pleased to join the 2025 Drug and Medical Device Seminar, hosted by DRI, May 7–9 at the Renaissance Nashville. This event brings together in-house counsel, outside counsel, and industry experts for timely discussions on litigation trends and best practices in drug and medical device cases.
On May 7 at 4:00 pm CT, IMS Senior Jury Consulting Advisor Jill Leibold, PhD will speak on the panel "Jury Selection in a Post-Pandemic World," sharing the latest data on juror perceptions of life sciences companies and practical strategies for identifying bias and selecting the best possible jury. Dr. Leibold will be joined by leading trial attorneys and in-house counsel for an interactive session exploring voir dire best practices, juror questionnaire use, and methods to address evolving juror attitudes in today’s political and social climate.
Dr. Leibold will also engage with attendees and share how IMS supports clients through the full case lifecycle. In addition to our litigation consulting services—including jury research, voir dire strategy, and trial preparation—IMS offers comprehensive expert witness services, advisory support, visual advocacy, and courtroom presentation technology designed to strengthen case outcomes in high-stakes disputes.
IMS is proud to support trial teams with data-backed strategies and services that drive success at every stage of litigation. Be sure to connect with Dr. Leibold in Nashville to learn more.
